Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Patient Experiences With Inbrija® - Non-interventional Assessment of Inhaled Levodopa for the Management of OFF Episodes in Parkinson's Disease: a Mixed-methods Study

NCT07797790 is registered in ClinicalTrials.gov with Merz Therapeutics GmbH as lead sponsor.

NCT NCT07797790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07797790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Patient Experiences With Inbrija® - Non-interventional Assessment of Inhaled Levodopa for the Management of OFF Episodes in Parkinson's Disease: a Mixed-methods Study
Lead sponsor
Merz Therapeutics GmbH
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2026
Completion date
September 30, 2027
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

off episodes of parkinson disease, parkinson disease (pd), parkinson's disease